Suraksha Diagnostic IPO: Comprehensive Peer Comparison with Healthcare Companies
This peer comparison evaluates Suraksha Diagnostic IPO against key competitors like Dr Lal PathLabs, Metropolis Healthcare, Thyrocare and Vijaya Diagnostic. By analysing essential financial metrics such as EPS, ROCE, ROE, P/E ratio, P/Bv, and Debt/Equity, investors can gain insights into the relative performance and valuation of these Healthcare companies. This comparison highlights the strengths and positioning of Suraksha Diagnostic in the competitive landscape of the Healthcare Industry.
Suraksha Diagnostic Limited IPO Peer Comparison |
|||||||||||
| Company Name | EPS | ROCE | ROE | P/E (x) | P/Bv | Debt/Equity | RoNW (%) | ||||
| Suraksha Diagnostic Limited | ₹4.41 | 21.46% | 14.09% | 99.93 | 12.27 | 0.20 | 14.09% | ||||
| Dr Lal PathLabs Limited | ₹48.1 | 25.2% | 20.4% | 62.0 | 12.4 | 0.10 | 20.4% | ||||
| Metropolis Healthcare Limited | ₹28.9 | 15.8% | 12.2% | 74.1 | 9.26 | 0.16 | 12.2% | ||||
| Thyrocare Technologies Limited | ₹16.8 | 18.2% | 13.3% | 58.3 | 10.8 | 0.04 | 13.3% | ||||
| Vijaya Diagnostic Centre Limited | ₹12.9 | 19.5% | 17.8% | 88.7 | 16.4 | 0.40 | 17.8% | ||||
Copyright @2020 Design & Developed by Info Web Software